Earnings

On cotton, new capital and comebacks to come

By GREGORY ZELLER // Capital infusions and superstar strategic advisors couldn’t save Applied DNA Sciences from another bottom-line beating in the first quarter of Fiscal 2017 – but the biotech appears ready to punch…


At Chembio, looking beyond the numbers

By GREGORY ZELLER // While it made “important advances … intended to prepare the company for growth,” according to its CEO, Chembio Diagnostic Systems has suffered another subpar fiscal quarter….





Systemax spins positives after 3Q dip

Despite impressive gains by its Industrial Products Group – including the group’s 27th consecutive quarter posting revenue growth and a nearly 10 percent increase in its sales force –Systemax Inc….